Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
12/2005
12/22/2005WO2004108903A8 Plant transformation and selection
12/22/2005WO2004104181A3 Nucleic acid processing methods, kits and devices
12/22/2005WO2004104179A3 Method for isolating and cloning high molecular weight polynucleotide molecules from the environment
12/22/2005WO2004094613A3 Polyvalent protein complex
12/22/2005WO2004087874A3 Novel nucleic acids and polypeptides
12/22/2005WO2004085623A3 A compact synthetic expression vector comprising double-stranded dna molecules and methods of use thereof
12/22/2005WO2004082370A3 Cardiac-preferred genetic alteration of transgenic rabbits
12/22/2005WO2004070007A3 Method for preparing single-stranded dna libraries
12/22/2005WO2004070004A3 Rat receptor tyrosine kinase, kdr
12/22/2005WO2004048595A3 Vascular-preferred promoters
12/22/2005WO2004026107A3 Kits and methods for assessing skin health
12/22/2005WO2003100000A3 Amplification and overexpression of oncogenes
12/22/2005WO2003057856A3 Dominant negative proteins and methods thereof
12/22/2005WO2002083874A3 Endothelial cell expression patterns
12/22/2005US20050283876 Campanula plant named 'Royal Wave'
12/22/2005US20050283861 transgenic seeds, plants; improved herbicide, insect and disease resistance; modified fatty acid and carbohydrate metabolism; male sterility
12/22/2005US20050283858 Brassica AHAS genes and gene alleles that provide resistance to imidazolinone herbicides
12/22/2005US20050283857 Peptides for inhibiting insects
12/22/2005US20050283856 Chimeric promoters for use in plants
12/22/2005US20050283855 Genes encoding acetolactate synthase
12/22/2005US20050283854 Recombinant vectors for use in position-independent transgene expression within chromatin
12/22/2005US20050283853 Methods and genetic compositions to limit outcrossing and undesired gene flow in crop plants
12/22/2005US20050283852 Specific genetic modification of the activity of trehalose-6-phosphate synthase and expression in a homologous or heterologous environment
12/22/2005US20050283851 Novel genes encoding proteins involved in proanthocyanidin synthesis
12/22/2005US20050283850 Multi-gene expression constructs containing modified inteins
12/22/2005US20050283848 Expression of eukaryotic peptides in plant plastids
12/22/2005US20050283847 Inhibition of gene expression using polynucleotide analogues
12/22/2005US20050283845 Method for producing non-human mammal having RNAi phenotype
12/22/2005US20050283844 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/22/2005US20050283843 Novel nuclear transfer technique through the processes of enucleation after activation to produce cloned mammals
12/22/2005US20050283842 Mipp1 homologous nucleic acids and proteins involved in the regulation of energy homeostatis
12/22/2005US20050283005 A peptide nucleic acid derivatives comprising a N-acetyl-1-(2-nitro-phenensulfonyl)-peperazin-2-one core group; oligomerization, for specific binding to DNA as well as RNA, stability
12/22/2005US20050283003 Reversible immobilization of arginine-tagged moieties on a silicate surface
12/22/2005US20050283000 Process for the production of a heterologous protein
12/22/2005US20050282999 Beta-amyloid peptide-binding proteins and polynucleotides encoding the same
12/22/2005US20050282766 Compositions and methods for treating neoplastic disease using chemotherapy and radiation sensitizers
12/22/2005US20050282765 Enzyme having S-adenosyl-L-homocysteine hydrolase (AHCY) type activity
12/22/2005US20050282764 Method of identifying nucleic acid compositions for muting expression of a gene
12/22/2005US20050282762 Antisense oligonucleotides for treating atopic diseases and neoplastic cell proliferation
12/22/2005US20050282761 Modulation of growth hormone receptor expression and insulin-like growth factor expression
12/22/2005US20050282760 Antisense modulation of ptpn12 expression
12/22/2005US20050282746 DNA encoding the receptor, a transformed cell expressing the receptor, producing the receptor by culturing the transformed cells; receptor binding assays; drug screening for agonists, antagonists, or allosteric modulators
12/22/2005US20050282745 Non-mammalian GnRH analogs and uses thereof in regulation of fertility and pregnancy
12/22/2005US20050282736 ligating recombinant intein domains to a linear synthetic protein to form a compound D1-X(n)-D2, where D1 and D2 are catalytic domains of an intein and X is a protein; cell-free; producing small cyclic peptides containing non-genetically encodable amino acids; for drugs
12/22/2005US20050282284 applying voltage across tissue, detecting ratio of electric current to voltage (impedance) as indication of electroporation, then adjusting voltage; electroconductivity
12/22/2005US20050282283 Electroporation apparatus and methods
12/22/2005US20050282282 Methods of use of viral vectors to deliver antigen to dendritic cells
12/22/2005US20050282281 Recombinant baculoviral vector containing protein transduction domain gene
12/22/2005US20050282280 Oncolytic adenoviral vectors encoding GM-CSF
12/22/2005US20050282279 Expression vector encoding coronavirus-like particle
12/22/2005US20050282278 Plant sugar transport proteins
12/22/2005US20050282275 Adipose-derived stem cells and lattices
12/22/2005US20050282274 Osteoblast precursors from human embryonic stem cells
12/22/2005US20050282265 Electroporation apparatus and methods
12/22/2005US20050282263 Flexible vaccine assembly and vaccine delivery platform
12/22/2005US20050282259 Nucleotide sequences for encoding of the lysR2-gene
12/22/2005US20050282258 Using transgenic escherichia as bioreactor for alanine production for use in processed food industry, animal feeds and human parenteral nutrition supplements
12/22/2005US20050282257 Biosynthesis; increasing phosphoenolpyruvate availability to metabolic pathway by selecting host cells which are phenotypically PTS-/Glucose+ and culturing; phosphotransferase transport system for carbohydrate transport
12/22/2005US20050282256 Adipocyte complement related protein zacrp13
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282254 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proteins
12/22/2005US20050282253 Inhibit endothelial cell proliferation, angiogenesis and cause tumor regression; antiproliferative, anticarcinogenic and antitumor agents
12/22/2005US20050282252 for isolation of DNA encoding anti-Rh(D) antibodies; isolation of DNA encoding antibodies directed against any red blood cells antigen or other cell antigen; for typing platelets by generating phage antibodies specific for a number of clinically important platelet antigens
12/22/2005US20050282251 Heparanase II, a novel human heparanase paralog
12/22/2005US20050282250 Method for the recombinant production and purification of protein kinases
12/22/2005US20050282249 Recombinant hexose oxidase, a method of producing same and use of such enzyme
12/22/2005US20050282247 Recombinant single chain antibody in heterotrophic algae for pathogen control and use
12/22/2005US20050282224 Method for carrying out a biochemical protocol in continuous flow in a microreactor
12/22/2005US20050282223 TR3-specific binding agents and methods for their use
12/22/2005US20050282222 Nematode PAN and ZP receptor-like sequences
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050282215 Isolated cytokine receptor LICR-2
12/22/2005US20050282202 Kits and processes for removing contaminants from nucleic acids in environmental and biological samples
12/22/2005US20050282187 Reagents and methods useful for detecting diseases of the urinary tract
12/22/2005US20050282185 Methods for detecting DNA originating from different individuals
12/22/2005US20050282184 Methods and reagents for molecular cloning
12/22/2005US20050282181 Methods for identifying functional antibodies
12/22/2005US20050282171 Purified thermostable Pyrococcus furiosus DNA polymerase I
12/22/2005US20050282169 Signatory sequences
12/22/2005US20050282166 Method for the expression of unknown environmental dna into adapted host cells
12/22/2005US20050282165 Diagnosis of Carcinoma Using RAIG1 Polypeptides
12/22/2005US20050282161 Novel phospholipase a2 and gene thereof
12/22/2005US20050282160 Allowing a transporter protein, whose function cannot be identified because of the inability to be transferred to a cell membrane in an exogenous gene expression system, to be transferred to the cell membrane by forming a fusion protein with a protein that promotes the transfer.
12/22/2005US20050282158 cutting the target nucleic acid at the site which hybridises with the padlock probe, a 3'-end of the cut target nucleic acid acts as a primer for rolling circle replication of the padlock probe; kits
12/22/2005US20050282157 Using oligonucleotide and peptide nucleic acid oligomers for use as diagnostic tool in monitoring cytosine methylation; detecting cell proliferative, inflammatory, connective, bone, nervous system and cardiovascular disorders
12/22/2005US20050282154 Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus
12/22/2005US20050282150 Identifying an inhibitor of cyclin E2 polypeptide/cyclic-dependent kinase-2 complex formation by allowing a cyclin E2 polypeptide having a specific sequence and cdk2 to spontaneously associate to form a cyclin E2 polypeptide/cdk2 complex; adding test compound; and assaying for a decrease in complex
12/22/2005US20050282147 Methods for assaying gene imprinting and methylated CpG islands
12/22/2005US20050281914 Methods and compositions involving endopeptidases PepO2 and PepO3
12/22/2005US20050281912 Chemically modified lipolytic enzyme
12/22/2005US20050281909 Extracting from flower head and petals; processing before oral adminstration; pigmentation
12/22/2005US20050281847 Vaccine composition
12/22/2005US20050281837 Immunologically active peptides with altered toxicity useful for the preparation of antipertussis vaccine
12/22/2005US20050281834 Altered peptide ligands
12/22/2005US20050281831 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors
12/22/2005US20050281824 Methods of using IMXP-888 and IMXP-888 antagonists
12/22/2005US20050281819 Evolving new molecular function
12/22/2005US20050281816 vaccines; treatment of allergies; three modules: a translocation module to transport MAT molecule into the interior of the cell; a targeting module which directs the MAT molecule to intracellular organelles involved in antigen processing and loading; and an antigen module which contains an allergen
12/22/2005US20050281812 Antibodies to insulin-like growth factor I receptor
12/22/2005US20050281804 Administering human recombinant alpha -L-iduronidase, carrier and polysorbate for therapy of mucopolysaccharidosis
1 ... 1892 1893 1894 1895 1896 1897 1898 1899 1900 1901 1902 1903 1904 1905 1906 1907 1908 1909 1910 1911 1912 ... 4023